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Abstract
The first step in the pathogenesis of enterotoxigenic Escherichia coli (ETEC) infections is adhesion of the bacterium to the
small intestinal epithelium. Adhesion of ETEC is mediated by a number of antigenically distinct colonization factors, and
among these, one of the most commonly detected is the non-fimbrial adhesin coli surface antigen 6 (CS6). The potential
carbohydrate recognition by CS6 was investigated by binding of recombinant CS6-expressing E. coli and purified CS6
protein to a large number of variant glycosphingolipids separated on thin-layer chromatograms. Thereby, a highly specific
binding of the CS6-expressing E. coli, and the purified CS6 protein, to sulfatide (SO3-3Galb1Cer) was obtained. The binding
of the CS6 protein and CS6-expressing bacteria to sulfatide was inhibited by dextran sulfate, but not by dextran, heparin,
galactose 4-sulfate or galactose 6-sulfate. When using recombinantly expressed and purified CssA and CssB subunits of the
CS6 complex, sulfatide binding was obtained with the CssB subunit, demonstrating that the glycosphingolipid binding
capacity of CS6 resides within this subunit. CS6-binding sulfatide was present in the small intestine of species susceptible to
CS6-mediated infection, e.g. humans and rabbits, but lacking in species not affected by CS6 ETEC, e.g. mice. The ability of
CS6-expressing ETEC to adhere to sulfatide in target small intestinal epithelium may thus contribute to virulence.
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Introduction
Attachment of microbes to cell surface receptors on the target
tissue is considered an essential step in the initiation, establishment
and maintenance of infection. As a result great interest has been
shown in the elucidation and identification of potential microbial
host receptors, the majority of which appear to be glycoconjugates
[1–3]. Glycoconjugates exhibit a characteristic and specific pattern
of expression, which is dependent on the animal species, individual
and cell type [4], thus explaining the phenomenon of tropism of
infection.
Adherence of enterotoxigenic Escherichia coli (ETEC) is mediated
by colonization factors (CFs), which usually are fimbrial structures
present on the bacterial cell surface. Infecting ETEC adhere to
and colonize the intestinal epithelium, and cause diarrhea
primarily by the production of heat-labile and/or heat-stable
enterotoxin (LT and ST respectively). Around 25 different CFs
have been identified [5], and one of the most commonly detected
is coli surface antigen 6 (CS6) [5–8]. CS6 is non-fimbrial, but the
overall structure of this adhesin has not yet been defined.
The CS6 operon required for assembly of the CS6 adhesin
contains four open reading frames [9]. Two heterologous major
structural subunits, CssA and CssB, are encoded by the cssA gene
and the cssB gene, respectively. The cssC gene encodes a chaperone
that was assumed to assist in the folding of CssA and CssB, and cssD
encodes a tentative usher involved in the transport of CssA and
CssB across the outer membrane. In a recent study a series of
deletionsweremade ineach ofthegenesofthe CS6operon,andthe
effects on the expression of CssA and CssB were examined [10].
Deletion of the chaperone CssC gave reduced levels of the CssA
subunit, while the expression of the CssB subunit was not affected.
Reduced levels of the CssA subunit was also obtained when the cssB
gene was deleted. Thus, the CssA subunit requires CssC for folding,
and is stabilized by interaction with CssB. Surprisingly, the
expression of the CssA and CssB subunits was not affected by
deletionoftheusherCssD,leadingtothe suggestionthat theusheris
not involved in the assembly or surface expression of CS6.
Using the rabbit non-ligated intestinal model (RITARD) it has
been shown that CS6 mediates binding of ETEC in rabbit
intestine, where colonization was obtained by a CS6-positive
strain, but not with the isogenic CS6-deficient strain [11]. A
previous study has also shown that the binding of CS6 to rabbit
enterocytes, and to mucus from rabbit and human intestines, was
abolished by treatment with meta-periodate, indicating the
involvement of carbohydrates in the binding process [12].
To further examine the potential role of carbohydrates as
adhesion receptors for CS6, the binding of purified CS6 protein
and recombinant CS6-expressing E. coli to glycosphingolipids was
investigated in the present study. Thereby, a specific interaction
between CS6-expressing bacteria, and purified CS6 protein, and
sulfatide (SO3-3Galb1Cer) was detected. Binding assays with
purified CssA and CssB subunits demonstrated that the CssB
PLoS ONE | www.plosone.org 1 February 2009 | Volume 4 | Issue 2 | e4487subunit carries the sulfatide binding capacity. Furthermore, a
correlation between the expression of sulfatide in target cells and
susceptibility to CS6-mediated ETEC infection was found.
Results
Characterization of the CS6 protein and the CssA and
CssB subunits
The three proteins were purified by the chromatgraphic steps
described in the Materials and methods section. The purified
proteins migrated as single bands, and the apparent molecular
weights were in agreement with the predicted molecular masses for
the constructed proteins 18483.61 for CssA (with the polyhistidine
tag) and 43,997.93 for CssB (fused to glutathione-S-transferase
carrying a His tag (Fig. 1).
Specific recognition of sulfatide by CS6-expressing E. coli
and the CS6 protein
In order to expose the CS6 protein to a large number of
potentially binding-active carbohydrate structures, mixtures of
glycosphingolipids from various sources separated on thin-layer
plates were used in the initial screening for carbohydrate
recognition by the CS6 adhesin. When using mixtures of acid
glycosphingolipids, i.e. sulfate-containing glycosphingolipids and
sialic acid- containing glycosphingolipids (gangliosides), a distinct
binding of the protein to a fast-migrating compound in the acid
fraction of human small intestine (Fig. 2, lane 2), human
meconium (lane 5), and human colon cancer (lane 6) was
observed. No binding of the CS6 protein to the more slow-
migrating compounds (mainly gangliosides) in the acid fractions,
or to any non-acid glycosphingolipids was obtained.
The binding of the CS6 protein to a fast-migrating compound
in the acid fraction of human small intestine and human
meconium directed our interest towards sulfate-containing glyco-
sphingolipids, since the major glycosphingolipid of these fractions
is sulfatide [13,14].
Next the binding of the CS6 protein, the recombinant CS6-
expressing E. coli strain TOP10-CS6, and the E. coli TOP10
background strain to a number of pure glycosphingolipids at
defined concentrations was tested in the chromatogram binding
assay. The results are exemplified in Fig. 3, and summarized in
Table 1. The majority of the glycosphingolipids tested, i.e. the non-
acid glycosphingolipids (Nos. 1,2,4,6-8, 10-21) and the ganglio-
sides (Nos. 22-27), were not recognized by the CS6 protein or the
Figure 1. Purified recombinant CS6, CssA and CssB proteins.
The protein preparations were separated on 10% (A) and 12% (B)
NuPAGE BisTris gels, and stained by Coomassie Brilliant Blue R-250. The
lanes on A were 1, molecular mass standards; 2, CS6 protein, and the
lanes on B were 1, molecular mass standards; 2, CssA protein (with
polyhistidine tag); 3, CssB protein (fused to glutathione-S-transferase
(26 kDa) and with polyhistidine tag).
doi:10.1371/journal.pone.0004487.g001
Figure 2. Binding of
125I-labeled CS6 adhesin to mixtures of glycosphingolipids on thin-layer chromatograms. Chemical detection by
anisaldehyde (A), and autoradiogram obtained by binding of
125I-labeled CS6 protein (B). The glycosphingolipids were separated on aluminum-
backed silica gel plates, using chloroform/methanol/water (60:35:8, by volume) as solvent system, and the binding assay was performed as described
under ‘‘Materials and methods’’. Autoradiography was for 12 h. The lanes were: Lane 1, acid glycosphingolipids of human hepatoma, 40 mg; Lane 2,
acid glycosphingolipids of human small intestine, 40 mg; Lane 3, acid glycosphingolipids of guinea pig erythrocytes, 40 mg; Lane 4, acid
glycosphingolipids of guinea pig stomach, 40 mg; Lane 5, acid glycosphingolipids of human meconium, 40 mg; Lane 6, acid glycosphingolipids of
human colon cancer, 40 mg; Lane 7, glucosylceramide (Glcb1Cer), 4 mg. The band in marked with an X in lane 3 was stained blue by anisaldehyde, and
thus a non-glycosphingolipid contaminant [36].
doi:10.1371/journal.pone.0004487.g002
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CS6-positive E. coli, but not the TOP10 vector strain, bound to
sulfatide (SO3-3Galb1Cer; No. 3 in Table 1; Fig. 3B and D, lanes
1 and 2, top band) and to sulfo-lactosylceramide (SO3-
Galb4Glcb1Cer; No. 5 in Table 1). No binding to galactosylcer-
amide (Galb1Cer; No. 1 in Table 1; Fig. 2, lane 3, top band,) or to
lactosylceramide (Galb4Glcb1Cer; No. 4 in Table 1) was
obtained, demonstrating that the sulfate group of sulfatide was
necessary for the interaction. However, sulfo-gangliotetraosylcer-
amide (SO3-3Galb3GalNAcb4Galb4Glcb1Cer; No. 9 in Table 1)
was not recognized by the CS6 protein or CS6-positive bacteria.
The TOP10 background strain binds to glycosphingolipids of
the ganglio-series, as e.g. fucosyl-gangliotetraosylceramide (Fuca2-
Galb3GalNAcb4Galb4Glcb1Cer; No. 8 in Table 1; Fig. 3C, lane
1, lower band) [15], and this binding was also obtained with the
recombinant TOP10-CS6 strain (Fig. 3D). However, while both
the CS6 protein and the CS6-positive E. coli bound to sulfatide, no
binding of the TOP10 background strain to this compound was
obtained, demonstrating that the recognition of sulfatide by the
TOP10-CS6 strain was indeed dependent on the CS6 protein.
The binding of the CS6 protein to glycosphingolipids was also
tested in the microtiter well assay. Also in this assay system
sulfatide was the preferred ligand (half-maximal binding at
approximately 100 ng), while other glycosphingolipids tested, as
the A7 type 2 glycosphingolipid (GalNAca3(Fuca2)Galb4(Fu-
ca3)GlcNAcb3Galb4Glcb1Cer) and the GM1 ganglioside
(Galb3GalNAcb4(NeuAca3)Galb4Glcb1Cer) gave no signal
(Fig. 4).
Figure 3. Binding of CS6 protein, vector E. coli TOP10 strain, and recombinant E. coli TOP10-CS6 strain to pure glycosphingolipids
on thin-layer chromatograms. Chemical detection by anisaldehyde (A), and autoradiograms obtained by binding of
125I-labeled CS6 protein (B),
35S-labeled E. coli TOP10 strain (C) and
35S-labeled E. coli TOP10-CS6 strain (D). The glycosphingolipids were separated on aluminum-backed silica gel
plates, using chloroform/methanol/water (60:35:8, by volume) as solvent system, and the binding assays were performed as described under
‘‘Materials and methods’’. Autoradiography was for 12 h. The lanes were: Lane 1, sulfatide (SO3-3Galb1Cer), 4 mg, and fucosyl-gangliotetraosylcer-
amide (Fuca2Galb3GalNAcb4Galb4Glcb1Cer), 4 mg; Lane 2, sulfatide (SO3-3Galb1Cer), 4 mg, and Forssman glycosphingolipid (GalNAca3GalNAcb3-
Gala4Galb4Glcb1Cer), 4 mg; Lane 3, galactosylceramide (Galb1Cer), 4 mg, and blood group H type 2 pentaglycosylceramide (Fuca2Galb4GlcNAcb3-
Galb4Glcb1Cer), 4 mg; Lane 4, blood group B type 2 hexaglycosylceramide (Gala3(Fuca2)Galb4GlcNAcb3Galb4Glcb1Cer), 4 mg; Lane 5, blood group A
type 2 hexaglycosylceramide (GalNAca3(Fuca2)Galb4GlcNAcb3Galb4Glcb1Cer), 4 mg; Lane 6, blood group A type 2 heptaglycosylceramide
(GalNAca3(Fuca2)Galb4(Fuca3)GlcNAcb3Galb4Glcb1Cer), 4 mg; Lane 7, globotriaosylceramide, (Gala4Galb4Glcb1Cer), 4 mg.
doi:10.1371/journal.pone.0004487.g003
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E. coli is inhibited by dextran sulfate
The ability of sulfated carbohydrates to interfere with the
binding of the CS6 adhesin to glycosphingolipids was examined by
incubating the CS6 protein, and CS6-expressing E. coli, with
dextran, dextran sulfate, heparin, galactose 4-sulfate, or galactose
6-sulfate before binding to glycosphingolipids on chromatograms
or in microtiter wells. As shown in Fig. 5, incubation with dextran
sulfate (1 mg/ml) ablated the sulfatide binding of the CS6-
expressing bacteria on thin-layer chromatograms (Fig. 5B). Also
the binding of the CS6 protein to sulfatide was reduced in a dose-
dependent manner by incubation with dextran sulfate (Fig. 5C). In
contrast, incubation with dextran (Fig. 5A), heparin, galactose 4-
sulfate, or galactose 6-sulfate (each 1 mg/ml) (not shown) did not
affect the binding of CS6-positive E. coli, or the CS6 protein, to
sulfatide.
Sulfatide binding is mediated by the CssB subunit
In order to evaluate the roles of the CssA and CssB structural
subunits of CS6 in the sulfatide binding process, these two proteins
were expressed separately. Chromatogram binding experiments
using
125I-labeled subunits gave a specific binding of the CssB
subunit to sulfatide, the major acid glycosphingolipid of piglet
intestine [16] (Fig. 6D, lane 8), in the same manner as the CS6
protein (Fig. 6B, lane 8). The CssA subunit, on the other hand,
bound to several major compounds both in the non-acid fractions
(Fig. 6C, lanes 1–5) and in the acid fractions (Fig. 6C, lanes 6–8),
in an unspecific manner demonstrating a general stickiness of this
Table 1. Binding of
125I-labeled native CS6 protein,
35S-labeled recombinant CS6-expressing Escherichia coli (TOP10-CS6) and
35S-
labeled background E. coli strain TOP10 to glycosphingolipids on thin-layer chromatograms.
No. Trivial name Structure CS6 protein TOP10-CS6 TOP 10
Simple compounds
1. Galactosylceramide Galb1Cer 2
a 22
2. Glucosylceramide Glcb1Cer 222
3. Sulfatide SO3-3Galb1Cer ++2
4. LacCer Galb4Glcb1Cer 222
5. Sulf-LacCer SO3-3Galb4Glcb1Cer ++2
6. Globotri Gala4Galb4Glcb1Cer 222
Ganglioseries
7. GgO3 GalNAcb4Galb4Glcb1Cer 222
8. Fuc-GgO4 Fuca2Galb3GalNAcb4Galb4Glcb1Cer 2 ++
9. Sulf-GgO4 SO3-3Galb3GalNAcb4Galb4Glcb1Cer 222
Neolactoseries
10. Neolactotetra Galb4GlcNAcb3Galb4Glcb1Cer 222
11. H5-2 Fuca2Galb4GlcNAcb3Galb4Glcb1Cer 222
12. B6-2 Gala3(Fuca2)Galb4GlcNAcb3Galb4Glcb1Cer 222
13. A6-2 GalNAca3(Fuca2)Galb4GlcNAcb3Galb4Glcb1Cer 222
14. A7-2 GalNAca3(Fuca2)Galb4(Fuca3)GlcNAcb3Galb4Glcb1Cer 222
Lactoseries
15. Le
a-5 Galb3(Fuca4)GlcNAcb3Galb4Glcb1Cer 222
16. Le
b-6 Fuca2Galb3(Fuca4)GlcNAcb3Galb4Glcb1Cer 222
17. A7-1 GalNAca3(Fuca2)Galb3(Fuca4)GlcNAcb3Galb4Glcb1Cer 222
18. B7-1 Gala3(Fuca2)Galb3(Fuca4)GlcNAcb3Galb4Glcb1Cer 222
Globoseries
19. Globotetra GalNAcb3Gala4Galb4Glcb1Cer 222
20. Isoglobotetra GalNAcb3Gala3Galb4Glcb1Cer 222
21. Forssman GalNAca3GalNAcb3Gala4Galb4Glcb1Cer 222
Gangliosides
22. GM3 NeuAca3Galb4Glcb1Cer 222
23. GD3 NeuAca8NeuAca3Galb4Glcb1Cer 222
24. GM1 Galb3GalNAcb4(NeuAca3)Galb4Glcb1Cer 222
25. GD1a NeuAca3Galb3GalNAcb4(NeuAca3)Galb4Glcb1Cer 222
26. NeuAca3SPG NeuAca3Galb4GlcNAcb3Galb4Glcb1Cer 222
aBinding is defined as follows: + denotes a binding when 4 mg of the glycosphingolipid was applied on the thin-layer chromatogram, while 2 denotes no binding even
at 4 mg.
doi:10.1371/journal.pone.0004487.t001
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CS6 adhesin responsible for sulfatide recognition resides within the
CssB subunit.
Presence of sulfatide in target small intestinal target cells
To assess the potential role of the sulfatide recognition by CS6
in target tissue adherence, the binding of recombinant CS6-
expressing E. coli to total acid glycosphingolipid fractions from
human, mouse and rabbit small intestines was examined. The
CS6-positive bacteria bound to a compound migrating as sulfatide
in the acid glycosphingolipid fractions from human small intestine
(Fig. 7, lanes 1–3), and rabbit small intestine (Fig. 7, lane 5), while
no binding to the acid glycosphingolipids from mouse small
intestine (Fig. 7, lane 4) occurred. Sulfatide isolated from human
small intestine was also recognized by the CS6-expressing bacteria
(Fig. 7D, lanes 3 and 4).
Discussion
Susceptibility to CS6-mediated infections varies among species,
and while e.g. humans and rabbits are highly susceptible, mice are
not colonized [11,17]. Here we report that the CssB subunit of the
CS6 protein confers a specific binding of this colonization factor to
a glycosphingolipid present in human and rabbit small intestine.
This CS6-binding compound was identified as sulfatide (SO3-
3Galb1Cer), which is the major acid glycosphingolipid of the
human small intestinal epithelial cells [13]. Binding of CS6-
expressing E. coli to sulfatides isolated from human small intestinal
epithelium was also demonstrated.
The binding studies with the recombinant CssA and CssB
subunits were done with proteins having remnant affinity tags. We
have now developed an affinity system based on a sulfate-carrying
polymer (Lebens et al., to be published). The CS6 protein and the
native CssB subunit, but not the native CssA subunit, are retained
on this affinity column, supporting the suggestion that the sulfatide
recognition of CS6 is mediated by the CssB subunit. Furthermore,
in a recent study the binding to CaCo-2 cells by recombinant E.
coli with deletion of the cssA gene was reported [10]. In contrast,
Figure 4. Binding of
125I-labeled CS6 protein to serial dilutions
of pure glycosphingolipids in microtiter wells. The assay was
performed as described in the Materials and methods section. The
results from one representative experiment out of three is shown.
doi:10.1371/journal.pone.0004487.g004
Figure 5. Effects of incubation of CS6 protein and recombinant
CS6-expressing E. coli with dextran and dextran sulfate.
Radiolabeled CS6 protein and recombinant CS6-expressing bacteria
were incubated with dextran or dextran sulfate (0.01–1 mg/ml) for 1 h
at room temperature. Thereafter the suspensions were utilized in the
chromatogram binding assay or the microtiter well assay as described
under ‘‘Materials and Methods’’. Autoradiograms obtained by binding
of
35S-labeled E. coli TOP10-CS6 strain incubated with dextran (A), and
with dextran sulfate (B). Autoradiography was for 12 h. The lanes were:
Lane 1, sulfatide (SO3-3Galb1Cer), 4 mg; Lane 2, sulfatide, 2 mg; Lane 3,
sulfatide, 1 mg. Binding of
125I-labeled CS6 protein, and
125I-labeled CS6
protein incubated with dextran sulfate, to pure glycosphingolipids in
microtiter wells (C).
doi:10.1371/journal.pone.0004487.g005
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not statistically different from that obtained with the background
strain.
Although sulfatide is a common constituent among small
intestinal glycosphingolipids of most species, its presence is not
obligatory, since it is not found in the small intestine of e.g. mouse,
rat, cod [18] or calves [19]. In mouse small intestinal epithelium,
the major sulfo-glycosphingolipid is sulf-gangliotetraosylceramide
(SO3-3Galb3GalNAcb4Galb4Glcb1Cer) [20], which, as we show
here, is not recognized by the CS6 protein or CS6-positive E. coli.
A dose-dependentreduction oftheCS6-mediated sulfatide binding
was obtained with the highlysulfated polymer dextran sulfate, but not
with dextran, demonstrating the importance of the sulfate group for
binding to occur. Preincubation with heparin, galactose 4-sulfate,
galactose 6-sulfate had no inhibitory effect, suggesting a specific
recognition of the sulfate group in 3-position of galactose as in
sulfatide, or glucose as in dextran sulfate. The recognition of sulfo-
lactosylceramide (SO3-3Galb4Glcb1Cer) by CS6 protein and the
CS6-expressing bacteria is in agreement with this suggestion.
However, sulfo-gangliotetraosylceramide (SO3-3Galb3GalNAcb4-
Galb4Glcb1Cer) was not recognized by the CS6 protein or CS6-
positive bacteria, although it has a terminal SO3-3Gal. Thus, a SO3-
3Galb3GalNAc sequence is not tolerated, suggesting a sterical
hindrance caused by the N-acetylgalactosamine.
Phenotypic expression of CS6 is associated with expression of
the heat-stable enterotoxin (ST-only and ST/LT strains), while it
is rarely observed in ETEC strains expressing only the heat-labile
enterotoxin [5,21]. There are two subtypes of the heat-stable
toxin, designated STa and STb. The receptor for STa, which is
associated with diarrhea in humans and animals, piglets, is the
extracellular domain of a trans-membrane guanylate cyclase type
C protein [22]. Interestingly, the STb subtype, which is primarily
associated with diarrhea in piglets, binds to sulfatide [23]. The
interaction of STb with sulfatide is not affected by dextran sulfate,
in contrast to the inhibitory effect observed for the sulfatide
binding of the CS6 protein.
Sulfatide recognition has also been reported for other
pathogens, including Mycoplasma pneumoniae [24], Bordetella pertussis
Figure 6. Binding of
125I-labeled CS6 protein, and CssA and CssB subunits, to mixtures of glycosphingolipids on thin-layer
chromatograms. Chemical detection by anisaldehyde (A), and autoradiograms obtained by binding of
125I-labeled CS6 (B), CssA (C) and CssB (D).
The glycosphingolipids were separated on aluminum-backed silica gel plates, using chloroform/methanol/water (60:35:8, by volume) as solvent
system, and the binding assay was performed as described under ‘‘Materials and methods’’. The lanes were: Lane 1, non-acid glycosphingolipids of
human erythrocytes, 40 mg; Lane 2, non-acid glycosphingolipids of human small intestine (Individual No. 1), 40 mg; Lane 3, non-acid
glycosphingolipids of human small intestine (Individual No. 2), 40 mg; Lane 4, non-acid glycosphingolipids of rat intestine, 40 mg; Lane 5, non-
acid glycosphingolipids of human meconium, 40 mg; Lane 6, calf brain gangliosides, 40 mg; Lane 7, acid glycosphingolipids of human erythrocytes,
40 mg; Lane 8, acid glycosphingolipids of piglet intestine, 40 mg. Autoradiography was for 12 h.
doi:10.1371/journal.pone.0004487.g006
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the case of H. pylori the heat-shock protein Hsp 70 has been
proposed to be the adhesin involved in sulfatide binding [29,30].
In addition, sulfatide is recognized by HP-NAP, the soluble
neutrophil-activating protein of H. pylori [31].
The sulfatide binding of CS6-expressing ETEC differs distinctly
from the glycosphingolipid specificity of CFA/I-fimbriated ETEC
[15]. The CFA/I minor tip subunit CfaE mediates hemaggluti-
nation and binding to CaCo-2 cells by binding to an as yet
unidentified receptor [32]. The major CfaB subunit of CFA/I
binds to a number of non-acid glycosphingolipids, including
glucosylceramide, lactosylceramide with phytosphingosine and/or
hydroxy fatty acids, neolactotetraosylceramide, gangliotriaosylcer-
amide, gangliotetraosylceramide, the H5 type 2 pentaglycosylcer-
amide, the Le
a-5 glycosphingolipid, the Le
x-5 glycosphingolipid
and the Le
y-6 glycosphingolipid. These non-acid glycosphingolip-
ids were also recognized by fimbriae with high sequence similarity
to CFA/I, i.e. CS1 and CS4 [12], but not by the CS6 adhesin
(present study). However, there is a large repertoire of CFs
expressed by ETEC, and for the major part of these CFs the
attachment sites are not yet defined. The mechanisms of
adherence mediated by ETEC CFs thus merits further studies.
Materials and Methods
Bacterial strains, culture and labeling
Recombinant CS6 adhesin was expressed in the E. coli strain
TOP10 as described by Tobias et al. [10], and the resulting
recombinant strain was designated TOP10-CS6. The TOP10-
CS6 strain was grown in CFA broth containing Casamino acids
10 g, yeast extract 1.5 g, MgSO4.7H2O 102 mg, and
MnCl2.4H2O 8 mg per liter (pH 7.4), supplemented with
ampicillin (100 mg/ml) at 37uC overnight with shaking. For
metabolic labeling, 100 ml of this bacterial suspension was
transferred to 10 ml of the same medium supplemented with
10 ml
35S-methionine (400 mCi; Amersham Pharmacia Biotech),
and grown for 2 h at 37uC with shaking. Thereafter, isopropyl-b-
D-thiogalactopyranoside (IPTG; Saveen Werner AB, Malmo ¨,
Figure 7. Binding of recombinant CS6-expressing E. coli to intestinal acid glycosphingolipids on thin-layer chromatograms. Chemical
detection by anisaldehyde (A and C), and autoradiograms obtained by binding of
35S-labeled CS6-expressing E. coli (TOP10-CS6) (B and D). The
glycosphingolipids were separated on aluminum-backed silica gel plates, using chloroform/methanol/water (60:35:8, by volume) as solvent system,
and the binding assays were performed as described under ‘‘Materials and methods’’. Autoradiography was for 12 h. The lanes on A and B were: Lane
1, acid glycosphingolipids of human small intestine (Individual No. 1), 40 mg; Lane 2, acid glycosphingolipids of human small intestine (Individual
No. 2), 40 mg; Lane 3, acid glycosphingolipids of human small intestine (Individual No. 3), 40 mg; Lane 4, acid glycosphingolipids of mouse small
intestine, 40 mg; Lane 5, acid glycosphingolipids of rabbit small intestine, 40 mg. The arrow denotes a band stained blue by anisaldehyde, and thus a
non-glycosphingolipid contaminant [36]. The lanes on C and D were: Lane 1, galactosylceramide (Galb1Cer), 4 mg; Lane 2, acid glycosphingolipids of
human small intestinal epithelium (Individual No. 4), 40 mg; Lane 3, sulfatide (SO3-3Galb1Cer) with phytosphingosine and hydroxy 16:0 fatty acid from
human small intestinal epithelium, 4 mg; Lane 4, sulfatide (SO3-3Galb1Cer) with phytosphingosine and hydroxy 24:1 fatty acid from human small
intestinal epithelium, 4 mg; Lane 5, sulf-gangliotetraosylceramide (SO3-3Galb3GalNAcb4Galb4Glcb1Cer), 4 mg.
doi:10.1371/journal.pone.0004487.g007
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bacteria were then incubated overnight. Bacteria were harvested,
washed three times in phosphate-buffered saline (PBS, pH 7.3),
then resuspended in PBS) containing 2% (w/v) bovine serum
albumin, 0.1% (w/v) NaN3 and 0.1% (w/v) Tween 20 (BSA/
PBS/TWEEN) to a bacterial density of 1610
8 colony forming
units/ml. The specific activity of bacterial suspensions was
approximately 1 cpm per 100 bacteria.
The same conditions (with omission of ampicillin and IPTG)
were used for culture and labeling of the background E. coli strain
TOP10.
Isolation of CS6 protein
The CS6 protein was isolated from the TOP10-CS6 recombi-
nant strain. An overnight culture of TOP10-CS6, grown in CFA
broth supplemented with 100 mg/ml of ampicillin, was diluted 1/
100 in the same medium and incubated for 2 h at 37uC and
150 rev/min. IPTG was then added into the medium to the final
concentration of 1 mM, and the bacteria were grown at 37uC and
150 rpm for 17 h. The bacterial culture was centrifuged twice at
100006g for 15 min. The supernatant was then filtered (0.2 mm
Amicon; Millipore, Bedford, MA) to remove bacterial cells. The
supernatant containing the CS6 was subjected to overnight
ammonium sulfate precipitation (50% saturation) at 4uC, and
the protein was recovered by centrifugation at 130006g for
30 min. The protein was dialyzed extensively against PBS and
stored at 270uC.
Production and purification of CssA and CssB
DNA fragments encoding the mature CssA and CssB proteins
were each amplified from the recombinant plasmid pJT-CS6 [10].
Each fragment was amplified so that it could be inserted directly
into an appropriate expression vector. The primers for the
amplification were:
cssA
Forward: 59-CCCCGGTCTCACAAGAGAACAGAAA-
TAGCGACTAAAAACTTC-39
Reverse: 59-CCCCGGTACCTTAATTAATTAGTTTACA-
TAGTAACCAACCATAACC-39
cssB
Forward: 59-CCCCGGTCTCACAAGGGAAACTGGCAA-
TATAAATCTCTGGATG-39
Reverse: 59-CGGTCTCAAGCTTAATTGCTGTAAAAT-
GATACAGTCAAATG-39
The amplified cssA fragment contained terminal BsaI and KpnI
sites that allowed directional cloning into a modified pBAD/His
plasmid [10] such that the resulting protein carried an amino
terminus polyhistidine tag that could be removed by enterokinase
digestion resulting in the native CssA protein. Protein expression
was induced by growth of the recombinant TOP10 strain in the
presence of 0.1% arabinose. This resulted in the accumulation of
the recombinant protein as cytoplasmic inclusion bodies, since the
signal peptide required for transport through the inner membrane
to the periplasm had been removed. The cells were harvested by
centrifugation and disrupted by lysozyme and DNase I treatment
followed by sonication. The inclusion bodies were separated from
the other cell debris by low speed centrifugation. Following
extensive washing of the inclusion bodies they were finally
dissolved in 6.5 M urea. The urea was removed by dialysis against
20 mM phosphate buffer, pH 7.4. When the urea had been
removed the his tagged protein was purified by affinity
chromatography using a nickel loaded His trap column (Amer-
sham Pharmacia Biotech, Uppsala, Sweden) attached to an A ¨KTA
FPLC apparatus (Pharmacia). The protein was loaded onto the
column in 20 mM phosphate buffer, pH 7.4, made 10 mM with
respect to imidazole, essentially according to the instructions of the
manufacturers. The protein was eluted using an imidazole
gradient from 10 mM up to 500 mM. The peak containing the
recombinant protein was identified by SDS-PAGE electrophoresis.
Fractions containing the protein were pooled and dialyzed against
20 mM phosphate buffer, pH 7.4, in order to remove the
imidazole. Purity of the resulting CssA product was estimated
from SDS-PAGE to be greater than 95%. Protein concentration
was determined by a modified Biuret assay.
Following cloning, CssB was not successfully expressed in the
same system. However, the mature CssB protein was also fused to
the 26 kDa glutathione-S-transferase (sj26GST) from Schistosoma
japonicum using an expression vector constructed in this laboratory.
The fusion protein was constructed such that cssB protein could be
cleaved from sj26GST carrier in two ways. Using thrombin for
cleavage, the CssB carries an amino terminus extension containing
a polyhistidine tag. Cleavage with enterokinase, however, leads to
removal of the native CssB protein from the sj26GST, carrier
which retains the polyhistidine tag. This allows the carrier protein
to be removed from the CssB using a chelating column charged
with nickel ions, even if the glutathione-S-transferase (GST) is not
active and cannot act as an affinity ligand. A strain carrying the
recombinant plasmid was grown up under inducing conditions in
which IPTG was added to the growth medium to a final
concentration of 1 mM. As with CssA, recombinant protein
accumulated in the cytoplasm of the bacteria as insoluble inclusion
bodies. The inclusion bodies were isolated and dissolved as
described above, and treated in exactly the same way as CssA,
taking advantage of the polyhistidine tag and avoiding difficulties
related to the reconstitution of active GST.
Electrophoresis
The protein preparations were separated on 10% or 12%
NuPAGE BisTris gels (Life Technologies Inc., Carlsbad, CA)
according to the instructions of the manufacturer, and stained by
Coomassie Brilliant Blue R-250.
125I-labeling
Aliquots of 100 mg of protein were labeled with
125I, using
Na
125I (100 mCi/ml; Amersham Pharmacia Biotech, Little
Chalfont, U.K.), according to the IODO-GEN protocol of the
manufacturer (Pierce, Rockford, IL), giving approximately
5610
3 cpm/mg protein.
Reference glycosphingolipids
Total acid and non-acid glycosphingolipid fractions were
prepared as described earlier [33]. Individual glycosphingolipids
were isolated by repeated chromatography on silicic acid columns
and by HPLC, and identified by mass spectrometry [34], and
1H-
NMR spectroscopy [35].
Thin-layer chromatography
Aluminum- or glass-backed silica gel 60 high performance thin-
layer chromatography plates (Merck, Darmstadt, Germany) were
used for thin-layer chromatography, and eluted with chloroform/
methanol/water (60:35:8, by volume) as solvent system. The
different glycosphingolipids were applied to the plates in quantities
of1–4 mg of pure glycosphingolipids and 40 mg of glycosphingolipid
mixtures. Chemical detection was done with anisaldehyde [36].
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Binding of
125I-labeled CS6 protein, CssA and CssB subunits,
and of
35S-labeled E. coli to glycosphingolipids on thin-layer
chromatograms was done as described previously [15]. Dried
chromatograms were dipped in diethylether/n-hexane (1:5 v/v)
containing 0.5% (w/v) polyisobutylmethacrylate for 1 min, dried,
and then blocked with BSA/PBS/TWEEN for 2 h at room
temperature. Thereafter the plates were incubated with
125I-labeled
CS6, CssA or CssB protein (1–5610
6 cpm/ml), or
35S-labeled
bacteria (1–5610
6 cpm/ml), diluted in BSA/PBS/TWEEN for
another 2 h at roomtemperature. After washingsix times with PBS,
and drying, the thin-layer plates were autoradiographed for 12 h
using XAR-5 x-ray films (Eastman Kodak, Rochester, NY).
Microtiter well binding assay
Binding of
125I-labeled CS6 protein to glycosphingolipids coated
in microtiter wells was performed as previously described [31]. In
short, serial dilutions (each dilution in triplicate) of pure
glycosphingolipids in methanol were applied in microtiter wells
(Falcon 3911, Becton Dickinson Labware, Oxnard, CA). When
the solvent had evaporated, the wells were blocked for 2 h with
200 ml of BSA/PBS/TWEEN. Thereafter, 50 ml of radiolabeled
CS6 protein diluted in BSA/PBS/TWEEN (approximately
2610
3 cpm/ml), were added per well and incubated for 4 h at
room temperature. After washing 6 times with PBS, the wells were
cut out and the radioactivity counted in a gamma counter.
Inhibition studies
As a test for possible inhibition of binding,
125I-labeled CS6
protein or
35S-labeled E. coli Top10-CS6 were incubated with
various concentrations (1 mg/ml, 0.1 mg/ml and 0.01 mg/ml) of
saccharides and anionic polysaccharides in PBS. Incubations were
done for 2 h at room temperature, and thereafter the suspensions
were diluted 40 times, and used in the chromatogram binding
assay (the
35S-labeled CS6-positive bacteria), or the microtiter well
assay (the
125I-labeled CS6 protein), as described above. Dextran
sulfate, dextran, and heparin were from VWR International AB.,
Stockholm, while galactose 4-sulfate, and galactose 6-sulfate were
from Sigma, St. Louis, MO.
Isolation and characterization of sulfatides from human
small intestinal epithelium
Total acid glycosphingolipids were isolated from mucosal
scrapings of the small intestine of one single individual as
described [33]. Part of the total acid fraction (13.3 mg) was
separated on an Iatrobeads (Iatrobeads 6RS-8060; Iatron
Laboratories, Tokyo) column (10 g), eluted with chloroform/
methanol/water 65:25:4 (by volume), 1065 ml, followed by
chloroform/methanol/water 40:40:12 (by volume), 2610 ml.
Aliquots of the fractions that were coloured by anisaldehyde on
thin-layer plates were tested for binding of the CS6 protein using
the chromatogram binding assay. Binding of the CS6 protein to
compounds migrating as reference sulfatide was obtained in four
consecutive fractions (fractions 4–7), and these fractions were
characterized by negative ion FAB mass spectrometry using a
JEOL SX-102A mass spectrometer (JEOL, Tokyo, Japan). The
ions were produced by 6 keV xenon atom bombardment, using
triethanolamine (Fluka, Buchs, Switzerland) as matrix, and an
accelerating voltage of 210 kV. Sulfatide with sphingosine and
hydroxy 24:0 fatty acid was thereby identified in fractions 4 and 5,
sulfatide with phytosphingosine and hydroxy 24:1 fatty acid in
fraction 6, and sulfatide with phytosphingosine and hydroxy 16:0
fatty acid in fraction 7 (data not shown).
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